Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Grade 1 Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01190449
What this trial is testing

Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 51
Testing effectiveness (Phase 2)Ended earlyNCT00089076
What this trial is testing

MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaCutaneous B-cell Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT00896922
What this trial is testing

S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911

Who this might be right for
Lymphoma
SWOG Cancer Research Network 180
Testing effectiveness (Phase 2)UnknownNCT00893477
What this trial is testing

GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
French Innovative Leukemia Organisation 60
Testing effectiveness (Phase 2)Study completedNCT00003849
What this trial is testing

Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 39
Testing effectiveness (Phase 2)Study completedNCT00003396
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277
Testing effectiveness (Phase 2)Study completedNCT00002880
What this trial is testing

Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 53
Testing effectiveness (Phase 2)Ended earlyNCT00057954
What this trial is testing

Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 6
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Testing effectiveness (Phase 2)Study completedNCT00003356
What this trial is testing

Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma

Who this might be right for
Lymphoma
University of Rochester 58
Testing effectiveness (Phase 2)Study completedNCT06745583
What this trial is testing

Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Who this might be right for
Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00003658
What this trial is testing

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00003615
What this trial is testing

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 77
Testing effectiveness (Phase 2)Ended earlyNCT00708942
What this trial is testing

Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1

Who this might be right for
Cervical Intraepithelial Neoplasia
Photocure 83
Testing effectiveness (Phase 2)Ended earlyNCT00288067
What this trial is testing

Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Adult Nodular Lymphocyte Predominant Hodgkin LymphomaB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+57 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT00003406
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Cancer Treatment Centers of America 30
Early research (Phase 1)Active Not RecruitingNCT02520791
What this trial is testing

Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

Who this might be right for
Advanced Primary Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-TypeRecurrent Grade 1 Follicular Lymphoma+16 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03341520
What this trial is testing

Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma

Who this might be right for
Stage II Grade 1 Follicular LymphomaStage II Grade 2 Follicular LymphomaStage I Follicular Lymphoma Grade 1+1 more
Heidelberg University 89
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07595393
What this trial is testing

A Dose-Finding Study of Amogammadex Sodium for Reversing Vecuronium and Rocuronium-Induced Neuromuscular Blockade

Who this might be right for
Reversing Vecuronium-Induced Neuromuscular Blockade in Patients Undergoing General Anesthesia SurgeryReversing Rocuronium-Induced Neuromuscular Blockade in Patients Undergoing General Anesthesia Surgery
Amckaus PTY LTD. 64
Next Page
21